Celularity is a biotechnology company that believes the answers to humanity’s greatest health concerns won’t come from outside treatments that challenge our immune system, but rather from galvanizing the cells already inside us to augment our biology and immunity.
Celularity currently has a portfolio of regenerative products in the market that are already changing the dynamics of wound healing. BIOVANCE and Interfyl are two of the products based on Celularity’s primary area of expertise—placenta-derived medicine. The third product is a unique therapy that stimulates healing from within.